ANGIOLINI, VALENTINA
 Distribuzione geografica
Continente #
EU - Europa 137
AS - Asia 38
NA - Nord America 24
SA - Sud America 2
Totale 201
Nazione #
IT - Italia 123
SG - Singapore 28
US - Stati Uniti d'America 23
FI - Finlandia 4
BG - Bulgaria 3
CN - Cina 3
AL - Albania 2
BR - Brasile 2
DE - Germania 2
IE - Irlanda 2
IN - India 2
MY - Malesia 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
CA - Canada 1
ID - Indonesia 1
KZ - Kazakistan 1
Totale 201
Città #
Rome 70
Singapore 21
Santa Clara 8
Lucca 4
Helsinki 3
Minturno 3
Sofia 3
Castel San Giorgio 2
Dublin 2
Isola della Scala 2
Milan 2
New York 2
Pescara 2
San Mauro Torinese 2
Senigallia 2
Tirana 2
Verona 2
Ashburn 1
Baranello 1
Camerino 1
Dubai 1
Fremont 1
Ghent 1
Jakarta 1
Karaganda 1
Kuala Lumpur 1
Lappeenranta 1
Latina 1
Manaus 1
Mariano Comense 1
Munich 1
Navi Mumbai 1
Niterói 1
Petaling Jaya 1
Solan 1
Tivoli 1
Toronto 1
Totale 152
Nome #
Hyaluronan-estradiol nanogels as potential drug carriers to target ER+ breast cancer cell line 57
Antitumoral effects of Bortezomib in malignant mesothelioma: evidence of mild endoplasmic reticulum stress in vitro and activation of T cell response in vivo 30
Tumor Microenvironment Remodeling in Gastrointestinal Cancer: Role of miRNAs as Biomarkers of Tumor Invasion 24
Dietary Polyphenols Effects on Focal Adhesion Plaques and Metalloproteinases in Cancer Invasiveness 21
 Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo 20
Bisphenol-A in Drinking Water Accelerates Mammary Cancerogenesis and Favors an Immunosuppressive Tumor Microenvironment in BALB–neuT Mice 18
The Combination of Bioavailable Concentrations of Curcumin and Resveratrol Shapes Immune Responses While Retaining the Ability to Reduce Cancer Cell Survival 16
Recent findings on the impact of ErbB receptors status on prognosis and therapy of head and neck squamous cell carcinoma 16
Curcumin potentiates the ErbB receptors inhibitor Afatinib for enhanced antitumor activity in malignant mesothelioma 12
Totale 214
Categoria #
all - tutte 1.095
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.095


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221 0 0 0 0 0 0 0 0 0 0 0 1
2022/202325 3 0 0 0 0 0 0 1 2 4 3 12
2023/2024120 3 12 11 15 16 10 7 16 5 5 6 14
2024/202568 10 4 21 11 22 0 0 0 0 0 0 0
Totale 214